FDA 510(k) FDA class 1 Substantially Equivalent 🇺🇸 United States

ALERE BINAXNOW INFLUENZA A & B CARD

K Number: K133411 · Decision Dec 5, 2013
Classifications
1
FEI Numbers
12
Registration Numbers
12
Same Product Code
17
Applicant Total
4
Review Days
28

Research this 510(k) in seconds

The Research Assistant summarizes clearance history, predicates and product-code trends — and cites every record.

Free to try · every answer cites its records

Basic Information

Device Name
ALERE BINAXNOW INFLUENZA A & B CARD
K Number
K133411
Device Class
FDA class 1
Clearance Type
Special
Regulation Number
866.3330
Medical Specialty
Microbiology
Decision
Substantially Equivalent
Statement or Summary
Summary
Applicant
Alere Scarborough, Inc D/B/A Binax, Inc.
Date Received
November 7, 2013
Decision Date
December 5, 2013
Product Code
GNX
Advisory Committee
Microbiology
Review Advisory Committee
MI
Third Party
N

Classifications

This FDA 510(k) entry is associated with 1 FDA classification via its product code.

Product Code Device Name
GNX Antigens, Cf (Including Cf Control), Influenza Virus A, B, C

Similar 510(k) Clearances

Other 510(k) clearances with the same product code (GNX), ordered by most recent decision date.

View all

Other Clearances by Alere Scarborough, Inc D/B/A Binax, Inc.

K Number Device Name
K141520 ALERE I INFLUENZA A & B
K133637 ALERE INFLUENZA A & B TEST
K103610 CLEARVIEW EXACT II INFLUENZA A & B TEST